Meloxicam Generis (Meloxicam)

• Meloxicam acts on inflammatory pathways to reduce pain and swelling in several rheumatic disorders.
• Osteoarthritis: improves joint function and reduces chronic pain.
• Rheumatoid arthritis: decreases inflammation and joint damage progression.
• Ankylosing spondylitis: alleviates spinal stiffness and pain.
• Acute pain: provides rapid relief of moderate to severe pain.

• Meloxicam selectively inhibits cyclooxygenase‑2 (COX‑2) enzymes, which reduces the synthesis of prostaglandins that mediate inflammation, pain, and fever. By sparing COX‑1 activity to a greater extent, it aims to maintain gastric mucosal protection while delivering anti‑inflammatory and analgesic effects.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Gastrointestinal upset: nausea, dyspepsia, or abdominal pain.
• Diarrhea or constipation.
• Headache or dizziness.
• Elevated blood pressure.
• Mild skin rash.
• Fluid retention or peripheral edema.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding, potentially perforation.
• Severe cardiovascular events such as myocardial infarction or stroke.
• Acute renal failure or worsening of chronic kidney disease.
• Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome).
• Hepatotoxicity with marked liver enzyme elevation.
• Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

• Gastrointestinal risk: assess history of ulcers or bleeding and consider gastro‑protective agents.
• Renal function: monitor serum creatinine and urine output, especially in the elderly.
• Cardiovascular health: evaluate for hypertension or heart disease and use the lowest effective dose.
• Concomitant medications: review use of anticoagulants, diuretics, or other NSAIDs.
• Hypersensitivity: discontinue if signs of severe allergic reaction appear.
• Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Lithium: reduced renal clearance leading to toxicity.
• Methotrexate: heightened risk of bone marrow suppression and hepatotoxicity.

Moderate Interactions (Monitor Closely):\n- Antihypertensives (ACE inhibitors, ARBs, beta‑blockers): possible reduction in blood pressure control.

• Diuretics (loop or thiazide): may impair renal function and increase electrolyte disturbances.
• Selective serotonin reuptake inhibitors (SSRIs): additive risk of gastrointestinal bleeding.
• Oral hypoglycemics: potential alteration of blood glucose control.